Portfolio swing drives $10.2m HY24 profit after $11.6m HY23 loss

What changed

Marlin's headline lines reversed sign across the board. Revenue (portfolio income and fair-value movements) turned positive at $12.4m from a $9.4m loss, PBT moved to $10.6m from a $10.6m loss, and NPAT reached $10.2m versus a $11.6m loss in HY23. Total equity expanded 24.5% to $201.6m, and liabilities shrank to $0.6m, consistent with a closed-end investment-company structure with no meaningful borrowings. Against that, net cash from operating activities deteriorated to an $11.4m outflow from a $7.5m inflow, and period-end cash fell to $3.5m from $5.5m. The interim dividend was lifted 12% to 1.86 cents per share.

What matters

• The result is portfolio-driven, not operating. The $21.8m revenue swing and the $21.2m PBT swing reflect fair-value and investment returns rather than any underlying trading business. Dividend income was broadly flat ($0.238m vs $0.219m), which is the only recurring cash yield visible in the excerpts.
• Cash-flow direction diverged from earnings. Operating cash flow swung by $18.9m in the opposite direction to NPAT. For a listed investment vehicle, this typically reflects net portfolio purchases/sales through operating lines, but the filing as supplied does not reconcile the movement.
• Balance sheet continues to carry the story. Equity of $201.6m against $0.6m in liabilities and a 5.05% interim ROE (versus –7.15%) show the recovery is accounting-driven via mark-to-market, not earned cash. The $2.9m DRP re-issue also supports equity without drawing on cash.

Expectations

No earnings or NAV targets are disclosed in the supplied material, and there is no forward-work context for an investment company of this type. The second-half shape analytics are noisy: FY23's negative HY23 base makes share-of-full-year ratios meaningless, and simply annualising HY24 revenue produces $24.7m versus FY23's $27.6m — a number that is more a function of market conditions in the period than a run-rate the release supports. The filing does not provide a basis to judge whether the HY24 reversal will persist into H2.

Quality of result

Durability is low by construction. Virtually all of the PBT swing sits in revaluation-type revenue, with recurring dividend income only around $0.2m. PBT grew 200% versus NPAT growth of 188.1%; the 11.9pp gap reflects a move from a $1.0m tax benefit to a $0.4m tax expense (effective rate 3.9%), so PBT is the cleaner read but both are dominated by mark-to-market. Cash conversion clearly deteriorated — an $11.4m operating outflow against $10.2m of reported NPAT — and receivables compressed to $0.1m from $0.8m, which trimmed receivable days from about 15 to 2 but is immaterial at this scale. The interim dividend (38.1% of NPAT) is being paid from an accounting profit that did not generate cash in the half.

Unresolved

• What drove the $18.9m deterioration in operating cash flow, and how much reflects net portfolio repositioning versus underlying cash yield?
• What is NTA/NAV per share at period end, and how does the $201.6m equity compare to the listed price — the filing as supplied does not disclose it?
• Is the $3.5m cash balance sufficient to meet the declared dividend and any subsequent distributions without further portfolio liquidation?
• Concentration, sector mix, and any realised-versus-unrealised split within the $12.4m revenue line are not disclosed in the excerpts.

This briefing cannot assess portfolio composition, NAV-based valuation, or whether the HY24 recovery has been sustained beyond balance date.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.